McKesson Corporation's Strategic Shift Towards Tech-Enabled Healthcare Services

Core Insights - McKesson Corporation is shifting its business model towards tech-enabled healthcare services to enhance its position in high-margin specialty and digital solutions [1] - Jefferies has set a new price target of $900 for McKesson, indicating a potential increase of 16.96% from its current trading price of $769.49, supported by strategic acquisitions [2][6] - The company's Q1 FY26 results demonstrate strong revenue growth and robust cash flow guidance, leading to raised long-term EPS targets [3][6] Financial Performance - McKesson's current stock price is $769.49, reflecting a 0.78% increase, with a trading range between $752.47 and $775.70 [4] - Over the past year, the stock has fluctuated between a high of $776.14 and a low of $492.39, with a market capitalization of approximately $95.71 billion [4] - Today's trading volume is 513,819 shares, indicating strong investor interest in the company's transformation [5] Strategic Initiatives - Recent acquisitions of PRISM Vision and Core Ventures are aimed at strengthening McKesson's presence in oncology, multispecialty, and technology-enabled segments [2][6] - The ongoing focus on tech-enabled healthcare services is expected to drive further growth and align with Jefferies' optimistic price target [5]